BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia

PROPEL 3 successfully met the primary endpoint of change from baseline in AHV at Week 52 (p<0.0001)- Change from baseline in AHV was ...
Law

FRCP and the Changing Nature of "Not Reasonably Accessible"

As courts continue to wrestle with Rule 26(b)(2)(B), a trend of parties using proportionality as a barrier to e-discovery production emerges. Under Rule 26(b)(2)(B), the Federal Rules of Civil ...